virus-like particle

Latest stories

  • in Healthcare IT, News

    PaxVax to Collaborate With NIH, DoD on Chikungunya Vaccine Development

    PaxVax has teamed up with the National Institutes of Health and the Defense Department to produce a commercial vaccine for the chikungunya virus. The company said Thursday it licensed NIH’s virus-like particle vaccine technology for chikungunya and aims to fully commercialize the vaccine through the collaborative effort. NIH currently evaluates the vaccine under a second-phase trial and PaxVax noted it plans […] More

  • in News, Products & Service

    Army Tests Ebola Vaccine Candidate With Yisheng Biopharma’s PIKA Adjuvant in Mice

    The U.S. Army has begun preclinical trials of its vaccine candidate against Ebola virus in combination with the PIKA adjuvant platform developed by China-based Yisheng Biopharma. Study results show that mice that received a combination of the Army Medical Research Institute of Infectious Diseases’ virus-like particle-based vaccine and Yisheng’s PIKA adjuvant platform demonstrated 100 percent […] More